TScan Therapeutics announced the resignation of Vice President of Finance Leiden Dworak and the appointment of CFO Jason A. Amello as principal accounting officer, effective April 10, 2026.
Key takeaways
Leiden Dworak resigned as Vice President of Finance and principal accounting officer, effective April 10, 2026.
The resignation was not due to any disagreements with the company regarding operations, policies, or practices.
CFO Jason A. Amello was appointed as the new principal accounting officer, effective April 10, 2026.
Mr. Amello will not receive additional compensation for assuming the principal accounting officer role.